Market Tracker

05/25 8:06am ET

Alimera Sciences Inc (NASDAQ:ALIM)

1.46
Delayed Data
As of May 24
 -0.02 / -1.35%
Today’s Change
1.01
Today|||52-Week Range
2.40
+35.19%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.48
Today’s open1.49
Day’s range1.44 - 1.50
Volume254,852
Average volume (3 months)591,327
Market cap$96.1M
Dividend yield--
Data as of 05/24/2017

Growth & Valuation

Earnings growth (last year)+8.70%
Earnings growth (this year)+79.37%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+53.01%
P/E ratioNM
Price/Sales1.66
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RNNRexahn Pharmaceutica...+0.06+1.53%
AGRXAgile Therapeutics I...+0.12+3.57%
AGTCApplied Genetic Tech...0.000.00%
OPHTOphthotech Corp-0.05-2.02%
Data as of 05/24/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$34.3M
Annual profit (last year)-$33.2M
Net profit margin-96.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts